戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 rent encephalitogenic determinants of myelin proteolipid protein.
2  chromosome which codes for the major myelin proteolipid protein.
3  a mutant form of the DM20 isoform of myelin proteolipid protein.
4 yelin autoantigens, myelin basic protein and proteolipid protein.
5 anscription factor at the promoter region of proteolipid protein.
6 sion of myelin basic protein and promoter of proteolipid protein.
7 s association with loss of the myelin marker proteolipid protein.
8 ithin the lesion, despite the persistence of proteolipid protein.
9                                           Ig-proteolipid protein 1 (Ig-PLP1) is an Ig chimera express
10 s, and the myelin associated glycoprotein to proteolipid protein 1 (MAG:PLP1) ratio, which declines i
11 ecurrent duplication of the dosage-sensitive proteolipid protein 1 (PLP1) gene but also by nonrecurre
12 eds of mutations in the X-linked myelin gene proteolipid protein 1 (PLP1) have been identified in hum
13 contrast, virtually all enteric glia express proteolipid protein 1 (PLP1).
14 e ratio of myelin-associated glycoprotein to proteolipid protein 1 and both endothelin 1 and vascular
15 e ratio of myelin-associated glycoprotein to proteolipid protein 1 and several other proteins involve
16 d ratio of myelin-associated glycoprotein to proteolipid protein 1 are likely to be protective physio
17                  Alternative splicing of the proteolipid protein 1 gene (PLP1) produces two forms, PL
18 ng leukodystrophy caused by mutations of the proteolipid protein 1 gene (PLP1), which is located on t
19 ry progressive multiple sclerosis to include proteolipid protein 1 gene mutations.
20                            Sequencing of the proteolipid protein 1 gene showed a novel mutation, Leu3
21 e ratio of myelin-associated glycoprotein to proteolipid protein 1 in post-mortem human brain tissue
22 e ratio of myelin-associated glycoprotein to proteolipid protein 1, correlated positively with the co
23 ptide ligand (APL) variants derived from the proteolipid protein-1 (PLP1) epitope were expressed on i
24          Ig-PLP1 is an Ig chimera expressing proteolipid protein-1 (PLP1) peptide corresponding to aa
25  with a retroviral vector designed to encode proteolipid protein (101-157) targeted for secretion.
26  of copolymers to I-A(s) in competition with proteolipid protein 139-151 (blocking), cytokine product
27 of Ag-specific tolerance using two regimens, proteolipid protein 139-151 (PLP139-151) peptide-coupled
28  and a DNA vaccine encoding the self-peptide proteolipid protein 139-151 (PLP139-151) provides protec
29 olecule VLA-4 antagonist, to regulate active proteolipid protein 139-151 (PLP139-151)-induced R-EAE.
30 ybridoma stimulated by a set of three myelin proteolipid protein 139-151 altered peptide ligands.
31 144) from an autoantigenic peptide of myelin proteolipid protein 139-151 by a single amino acid subst
32                 Likewise, when combined with proteolipid protein 139-151 in CFA, GM-CSF fused to prot
33 ipid protein 139-151 in CFA, GM-CSF fused to proteolipid protein 139-151 peptide inhibited EAE in SJL
34 ke E2, drastically suppressed EAE induced by proteolipid protein 139-151 peptide when given at initia
35 alomyelitis (EAE) induced in SJL/J mice with proteolipid protein 139-151 was demonstrated by using th
36              T cell lines were selected from proteolipid protein 139-151-immunized female SJL mice in
37 ncephalomyelitis (EAE) in humanized mice and proteolipid protein 139-151-induced EAE in SJL/J mice.
38 hat anti-GITR mAb treatment of SJL mice with proteolipid protein 139-151-induced experimental autoimm
39 ively induced EAE were able to present Ag to proteolipid protein 139-151-specific T cell lines in vit
40                         Adoptive transfer of proteolipid protein 139-151-specific T cell lines was us
41 e inhibitors crossreacted with MBP 85-99- or proteolipid protein 139-151-specific T cells.
42 nduced unresponsiveness to the self peptide, proteolipid protein 139-151.
43 he frequency and effector function of myelin proteolipid proteins 139-151/I-A(s)-tetramer(+) cells in
44 tified a promoter variant (-113C>A) in PLP2 (proteolipid protein 2) that results in an approximately
45 n immunoglobulin gene superfamily member, or proteolipid proteins, 4-hydrophobic domain-motif protein
46  and TNF-alpha in response to the immunogen, proteolipid protein 56-70.
47 ice injected i.p. with a peptide fragment of proteolipid protein (a candidate autoantigen in multiple
48 ression is associated with downregulation of proteolipid protein, a highly abundant myelin sheath com
49 ignals may control the surface expression of proteolipid protein, a process that involves reduced end
50 indicate that the adhesive properties of the proteolipid protein, along with the reduction of sialic
51  pathology and to mediate neuroprotection in proteolipid protein alpha-syn (PLP-SYN) mice, a transgen
52 reflected in decreased expression of MBP and proteolipid protein and a reduction in the total number
53                   We revisit the role of the proteolipid protein and analyze the contribution of olig
54                                              Proteolipid protein and carbonic anhydrase-II transcript
55 myelin proteins that are not MMP substrates (proteolipid protein and DM20).
56                            The two proteins, proteolipid protein and DM20, which are encoded by alter
57  a point mutation in the mouse gene encoding proteolipid protein and is characterized by severe dysmy
58 ociated with oligodendroglial lineage (e.g., proteolipid protein and PMP-22).
59 elitis, stimulation of lymph node cells with proteolipid protein and recombinant murine interleukin (
60  the amounts of myelin basic protein, myelin proteolipid protein, and 2',3'-cyclic nucleotide 3'-phos
61 teins including myelin basic protein, myelin proteolipid protein, and 2'3'-cyclic nucleotide 3'-phosp
62 sociates with myelin proteins such as myelin proteolipid protein, and assembles lipid-rich microdomai
63 teins, including myelin basic protein (MBP), proteolipid protein, and myelin oligodendrocyte glycopro
64 for reactivity against myelin basic protein, proteolipid protein, and myelin oligodendrocyte glycopro
65 ein and a decrease in neurofilament protein, proteolipid protein, and several pro-inflammatory marker
66 n oligodendrocyte glycoprotein (MOG)35-55 in proteolipid protein- and MOG-induced models of EAE, resp
67                    However, we now find that proteolipid proteins are actually major myelin constitue
68                    In conclusion, P0 and the proteolipid proteins are evolving in parallel in myelina
69 The loss of Cx47 was associated with loss of proteolipid protein at the chronic stage of MHV-A59 infe
70 nic Ags (guinea pig myelin basic protein and proteolipid protein) by lymph node cells from animals im
71 duced Nf1 loss of function with an inducible proteolipid protein Cre allele.
72 ts and are specific for two different myelin proteolipid protein-derived peptides presented by HLA-A2
73 t immunization with myelin basic protein and proteolipid protein determinants results in clinical dis
74 -cell responses to the immunodominant myelin proteolipid protein epitope (PLP139-151) did not arise b
75 (HI574-586) of an immunodominant self-myelin proteolipid protein epitope (PLP139-151) induced a rapid
76 nization of SJL mice with the immunodominant proteolipid protein epitope, PLP139-151, surface express
77 re able to endogenously present a variety of proteolipid protein epitopes to specific Th1 lines.
78 taining human myelin basic protein and human proteolipid protein epitopes, prevented clinical symptom
79 ll response against myelin basic protein and proteolipid protein epitopes.
80                 Th1 cells reactive to myelin proteolipid protein expressed more H1R and less H2R than
81 Xenopus, DM gamma, a membrane protein of the proteolipid protein family, is expressed in a subset of
82 nding of the disease, dosage sensitivity and proteolipid protein function during myelinogenesis.
83                                          The proteolipid protein gene (PLP) is normally present at ch
84                  Alternative products of the proteolipid protein gene (PLP), proteolipid protein (PLP
85 h conditions resulting from mutations in the proteolipid protein gene (PLP).
86 stem (CNS) caused by mutations involving the proteolipid protein gene (PLP).
87 ease (PMD) is a leukodystrophy linked to the proteolipid protein gene (PLP).
88                          Although the myelin proteolipid protein gene (Plp1) is highly expressed in t
89 mpy mutant mouse has a point mutation in the proteolipid protein gene (plp1).
90 genomic duplications of the dosage-sensitive proteolipid protein gene (PLP1).
91 activation in the peripheral lymphocytes nor proteolipid protein gene coding alterations were identif
92  indicate that, occasionally, females with a proteolipid protein gene duplication can manifest an ear
93 uorescent in situ hybridization identified a proteolipid protein gene duplication in both patients.
94 oscopic duplication that contains the entire proteolipid protein gene is the major cause of Pelizaeus
95                           Duplication of the proteolipid protein gene is the most common molecular ab
96 zaeus-Merzbacher disease, duplication of the proteolipid protein gene PLP1 is responsible, whereas de
97                                          The proteolipid protein gene products DM-20 and PLP are adhe
98 survival, differentiation, and expression of proteolipid protein gene products.
99 n by oligodendrocytes expressing one copy of proteolipid protein gene secondary to selection for a fa
100 axons, and subsequently expressed the myelin proteolipid protein gene, initiating remyelination.
101 fect disease induced after immunization with proteolipid protein immunodominant peptide plus MBP.
102 c F1 mice, immunized 12-15 days earlier with proteolipid protein in complete Freund's adjuvant, were
103 ulates cell surface expression of the myelin proteolipid protein in cultured oligodendrocytes in unex
104 y acidic protein in Alexander disease and of proteolipid protein in hypomyelinating disorders such as
105                    In vitro stimulation with proteolipid protein in the presence of rmIL-12 was assoc
106 ought to be completely replaced by the newer proteolipid proteins in the terrestrial vertebrate CNS.
107  course is well documented for both MBP- and proteolipid protein-induced EAE, and recently has been s
108  major intrinsic membrane protein of myelin, proteolipid protein, interacts with rafts in oligodendro
109                We have found that the myelin proteolipid protein is critical to regulating OPC migrat
110 issue, Yin et al. study mutant mice in which proteolipid protein is replaced by the peripheral myelin
111 ling view has been that expression of P0 and proteolipid proteins is mutually exclusive; P0, which me
112 ons of myelin-specific proteins (MBP, myelin proteolipid protein, MAG, and 2',3'-cyclic nucleotide,3'
113        Transcripts for myelin genes, such as proteolipid protein, MAG, MBP, and myelin oligodendrocyt
114 uced by myelin oligodendrocyte glycoprotein, proteolipid protein, myelin basic protein, and renal tub
115  expression, including myelin basic protein, proteolipid protein, myelin oligodendrocyte glycoprotein
116 erized myelin antigens myelin basic protein, proteolipid protein, or myelin oligodendrocyte glycoprot
117 roliferative response and IL-2 production of proteolipid protein p139-151-specific T cells were signi
118 ctive T cells was demonstrated by inhibiting proteolipid protein (p139-151)-induced EAE and finding t
119 JL/J mouse by adoptive transfer of activated proteolipid protein peptide (PLP) 139-151-specific Th1 c
120 on with Listeria monocytogenes (LM) encoding proteolipid protein peptide (PLP) amino acids 178-191 (L
121 latory signals, impaired memory responses to proteolipid protein peptide (PLP), and do not develop PL
122                       Oral administration of proteolipid protein peptide (PLP139-151) increased MCP-1
123 zed for disease with encephalitogenic myelin proteolipid protein peptide 139 to 151, and analysis was
124             By comparing a wide age range of proteolipid protein peptide 139-151 immunized mice, we f
125                SJL mice were challenged with proteolipid protein peptide 139-151 to induce EAE and or
126 specific for MBP exon 2, MBP peptide 89-101, proteolipid protein peptide 139-151, and OVA gave stimul
127  of a CD4+, Th1, VB2+ encephalitogenic SJL/J proteolipid protein peptide 139-151-specific T cell clon
128 vere course of EAE with epitope spreading to proteolipid protein peptide 43-64.
129 ecific for the relapse epitope consisting of proteolipid protein peptide amino acids 139-151 clustere
130 odel of MS, was induced by immunization with proteolipid protein peptide in SJL/J mice.
131      During acute relapsing EAE induced by a proteolipid protein peptide of amino acids 178-191, tran
132 e are also resistant to initiation of EAE by proteolipid protein peptide PLP(178-191).
133 AR inhibited their capability to present the proteolipid protein peptide to PLP(139-151)-specific T c
134  encephalomyelitis using an encephalitogenic proteolipid protein peptide, PLP(139-151).
135 t detectable in the infiltrates of mice with proteolipid protein peptide-induced experimental autoimm
136 ectively, these results indicate that myelin proteolipid protein peptide-specific CD8+ CTL may be an
137 litis (EAE) was induced by immunization with proteolipid protein peptide.
138 ntal autoimmune encephalomyelitis induced by proteolipid protein, peptide 139-151-specific T cell lin
139      In relapsing/remitting EAE induced with proteolipid protein peptide139-151, lithium administered
140   Our data showed that an extensive array of proteolipid protein peptides could elicit autoreactivity
141  encoded by alternative transcripts from the proteolipid protein ( PLP ) gene, are major components o
142                                           Ig-proteolipid protein (PLP) 1 and Ig-myelin oligodendrocyt
143 ospot analysis (ELISPOT) assays, we followed proteolipid protein (PLP) 139--151-specific T cells enga
144  study, we have identified an MHC variant of proteolipid protein (PLP) 139-151 (145D) that renders PL
145 encephalitogenic epitope of a myelin antigen proteolipid protein (PLP) 139-151 in the peripheral repe
146                 In this study, using the SJL proteolipid protein (PLP) 139-151 peptide EAE model, we
147 ompassing the immunodominant myelin epitope, proteolipid protein (PLP) 139-151, into the coding regio
148    Female B10.S mice are highly resistant to proteolipid protein (PLP) 139-151-induced experimental a
149 mpared the ability of anti-VLA-4 to regulate proteolipid protein (PLP) 139-151-induced R-EAE when adm
150 tides, myelin basic protein (MBP) 87-106 and proteolipid protein (PLP) 175-192, that are considered t
151      A protein complex containing the myelin proteolipid protein (PLP) and alphav integrin modulated
152          Mutated HSP proteins include myelin proteolipid protein (PLP) and axon-enriched proteins inv
153 ducts of the proteolipid protein gene (PLP), proteolipid protein (PLP) and DM20, are major components
154 matic epitope mapping of responses to myelin proteolipid protein (PLP) as well as assaying responses
155  mutation in exon 3B of the PLP altering the proteolipid protein (PLP) but not the alternatively spli
156 ping series of 265 12-mer peptides of myelin proteolipid protein (PLP) by patients with isolated mono
157 s of myelin, myelin basic protein (MBP), and proteolipid protein (PLP) during postnatal brain develop
158 ific for the immunodominant encephalitogenic proteolipid protein (PLP) epitope (PLP139-151) as assess
159  of 13 aa with the dominant encephalitogenic proteolipid protein (PLP) epitope PLP(139-151).
160  SJL mice initiated by immunization with the proteolipid protein (PLP) epitope PLP139-151 is associat
161 nti-IL-23p19 during active disease inhibited proteolipid protein (PLP) epitope spreading and prevente
162 states in different cell compartments of the proteolipid protein (PLP) expressed in COS-7 cells.
163  mice induced by MP4, a myelin basic protein-proteolipid protein (PLP) fusion protein.
164                                   The myelin proteolipid protein (PLP) gene (i.e., the PLP/DM20 gene)
165      Overexpression or lack of expression of proteolipid protein (PLP) gene by oligodendrocytes cause
166                                          The proteolipid protein (PLP) gene encodes two myelin-specif
167 inhibitory effect on OLP differentiation and proteolipid protein (PLP) gene expression.
168 enes containing portions of the mouse myelin proteolipid protein (PLP) gene fused to the lacZ reporte
169                          Duplications of the proteolipid protein (PLP) gene have been found in a prop
170 nt protein (EGFP) driven by the mouse myelin proteolipid protein (PLP) gene promoter have been develo
171  of the CNS, resulting from mutations in the proteolipid protein (PLP) gene.
172 mutations, deletions, or duplications of the proteolipid protein (PLP) gene.
173 mutations, deletions, or duplications of the proteolipid protein (PLP) gene.
174                                              Proteolipid protein (PLP) has been postulated to play a
175 areas, an increased number of OGs expressing proteolipid protein (PLP) mRNA compared with those expre
176 rade astrocytomas contained a high number of proteolipid protein (PLP) mRNA-positive cells and that t
177 ic for an encephalitogenic peptide of myelin proteolipid protein (PLP) peptide 139-151 (HSLGKWLGHPDKF
178                               We used myelin proteolipid protein (PLP) peptide 139-151 and its analog
179          In B10.S mice immunized with myelin proteolipid protein (PLP) peptide 139-151, both PD-L1 an
180 B6) specific for the encephalitogenic myelin proteolipid protein (PLP) peptide 139-151, on the experi
181  encephalomyelitis (EAE) induced with myelin proteolipid protein (PLP) peptide 139-151, whereas H-2 c
182                  For instance, delivery of a proteolipid protein (PLP) peptide on Ig boosts the neona
183 ning of the BBB in EAE mice immunized to the proteolipid protein (PLP) peptide, PLP 139-151, with or
184 eptides derived from sequences of the myelin proteolipid protein (PLP) presented by HLA class I molec
185 nit of functional NMDARs, using an inducible proteolipid protein (Plp) promoter-driven Cre-loxP recom
186 n the oligodendroglia lineage, driven by the proteolipid protein (PLP) promoter.
187  encephalomyelitis (EAE) induced with myelin proteolipid protein (PLP) residues 139-151 (HSLGKWLGHPDK
188            To address this issue we used the proteolipid protein (PLP) sequence 139-151 (hereafter re
189 1, a chimera expressing the encephalitogenic proteolipid protein (PLP) sequence 139-151, induced devi
190 c presentation system, we demonstrate that a proteolipid protein (PLP) TCR antagonist peptide (PLP-LR
191                      Like MS, EAE induced by proteolipid protein (PLP) usually follows the form of a
192 ized with the p139-151 determinant of myelin proteolipid protein (PLP) were transfected with a DNA co
193 enic mice on the SJL background specific for proteolipid protein (PLP)(139-151) develop a high incide
194       Drug treated SJL/J mice immunized with proteolipid protein (PLP)(139-151) peptide had attenuate
195 Multiple Ag peptides (MAPs) containing eight proteolipid protein (PLP)(139-151) peptides arranged aro
196 sing the HLA-DR or -DQ gene), we showed that proteolipid protein (PLP)(91-110) peptide induced classi
197 -cyclic-nucleotide 3'-phosphodiesterase, and proteolipid protein (PLP)) in primary human oligodendroc
198 -expressing cells co-expressed mRNA encoding proteolipid protein (PLP), a mature oligodendrocyte mark
199         EAE was induced in SJL mice by using proteolipid protein (PLP), and mice were treated with ei
200  allergic encephalomyelitis in SJL mice with proteolipid protein (PLP), brain ICOS mRNA and protein w
201  intervene in autoimmune responses to myelin proteolipid protein (PLP), encephalitogenic epitopes mus
202 ntaining both myelin basic protein (MBP) and proteolipid protein (PLP), induced antigen specific MBP
203 e, we show that NG2+ cells express mRNAs for proteolipid protein (PLP), myelin basic protein, and 2',
204 th antibodies to myelin basic protein (MBP), proteolipid protein (PLP), myelin-associated glycoprotei
205 undrum with regard to the function of myelin proteolipid protein (PLP), one of the major proteins in
206 ge when a tetraspan membrane protein, myelin proteolipid protein (PLP), replaced the type I integral
207 hybridization with oligonucleotide probes to proteolipid protein (PLP), the major protein in central
208                                              Proteolipid protein (PLP), the major protein of central
209                    A new role for the myelin proteolipid protein (PLP), the most abundant protein of
210 ssociated glycoprotein (MAG) but not P(0) or proteolipid protein (PLP), the structural proteins of co
211 ant of a non- glycosylated membrane protein, proteolipid protein (PLP), to examine the quality contro
212 expression of myelin basic protein (MBP) and proteolipid protein (PLP), two major myelin-specific pro
213 lization of another myelin-specific protein, proteolipid protein (PLP), was unaltered.
214                          Using antibodies to proteolipid protein (PLP), we found a total of 70 cortic
215  were determined from animals immunized with proteolipid protein (PLP)-139-151 (disease agonist), PLP
216                                              Proteolipid protein (PLP)-139-151 is the dominant enceph
217 ism of a rTCR ligand (RTL) construct (I-A(s)/proteolipid protein (PLP)-139-151 peptide = RTL401) for
218 P1 and Ig-PLP-LR are chimeric Igs expressing proteolipid protein (PLP)-derived T cell agonist (PLP1)
219 mice, which are highly susceptible to myelin proteolipid protein (PLP)-induced experimental autoimmun
220  the human HLA-DRB1*0301 gene predisposes to proteolipid protein (PLP)-induced experimental autoimmun
221                        Fixed preparations of proteolipid protein (PLP)-null mouse spinal cord show my
222               Conversely, Tsc1 deletion from proteolipid protein (PLP)-positive oligodendrocytes slow
223 (ELISPOT) assays to study, directly ex vivo, proteolipid protein (PLP)-specific memory cell reactivit
224 ) selectively modifies cytokine secretion in proteolipid protein (PLP)-specific, CD4+ T cell clones i
225                              The transfer of proteolipid protein (PLP)-stimulated lymph node cells to
226 toimmune encephalomyelitis (EAE) with myelin proteolipid protein (PLP).
227 ding proteins, and, surprisingly, the myelin proteolipid protein (PLP).
228 yelin sheath, myelin basic protein (MBP) and proteolipid protein (PLP).
229 r ribonucleoprotein (hnRNP) H and F regulate proteolipid protein (PLP)/DM20 alternative splicing.
230 conserved G runs, G1M2 and ISE, regulate the proteolipid protein (PLP)/DM20 ratio.
231 n (Ig) chimera carrying the encephalitogenic proteolipid protein (PLP)1 peptide corresponding to amin
232                                           Ig-proteolipid protein (PLP)1, an Ig carrying a PLP1 peptid
233 +CD25-Foxp3- T cells specific for the myelin proteolipid protein (PLP)139-151 peptide can be converte
234 DEC205-mediated delivery of the self-peptide proteolipid protein (PLP)139-151 to DCs ameliorated clin
235 w chimeras, we show that activation of naive proteolipid protein (PLP)139-151-specific T cells in SJL
236 d multitransmembrane domain proteins, myelin proteolipid protein (PLP, 30 kDa) and DM-20 (26 kDa), fr
237         We also provide evidence that myelin proteolipid protein (PLP/DM-20)-positive cells in the la
238 ion of 19 base pairs (bp) in intron 3 of the proteolipid protein (PLP/DM20) gene causes a neurologica
239 ed with an autoantigenic peptide from myelin proteolipid protein (PLP; PLP(139-151)) and used it to a
240 e significant homology with the major myelin proteolipid protein, PLP/DM20.
241                                              Proteolipid protein (PLP1) and its alternatively spliced
242 e three, and in one case, five copies of the proteolipid protein (PLP1) gene.
243 editary spastic paraplegia (HSP) type 2 is a proteolipid protein (PLP1)-related genetic disorder that
244  gene encoding the major CNS myelin protein, proteolipid protein (PLP1, previously PLP).
245 g the immunodominant encephalitogenic myelin proteolipid protein (PLP139-151) epitope.
246         T cell epitope peptides derived from proteolipid protein (PLP139-151) or myelin basic protein
247 ng a minigene for residues 139-151 of myelin proteolipid protein (PLP139-151), a pathogenic self-Ag.
248 ent of oligomerized T cell epitope of myelin proteolipid protein (PLP139-151).
249 es forming myelin basic protein (MBP)(+) and proteolipid protein-positive myelin was impaired.
250 F-beta mRNA and protein in normal as well as proteolipid protein-primed splenocytes.
251 oxed conditional allele was crossed with the proteolipid protein promoter-driven inducible Cre allele
252   Our data suggest that NG2(+)/PDGFRalpha(+) proteolipid protein promoter-expressing progenitors gene
253 st cells can induce gene expression from the proteolipid protein promoter.
254 fluorescent protein under the control of the proteolipid protein promoter.
255 ytes using an inducible cre regulated by the proteolipid protein promoter.
256 led by GFP transgenically expressed from the proteolipid protein promoter.
257                        Enhanced responses to proteolipid protein self peptide were associated with re
258                 Finally, we show that myelin proteolipid protein-specific autoreactive T cells transd
259                Here we report that tolerized proteolipid protein-specific lymph node cells regain the
260 our study, we used the previously described [proteolipid protein/suppressor of cytokine signaling 1 (
261 enerated a transgenic mouse line [PLP/SOCS1 (proteolipid protein/suppressor of cytokine signaling 1)]
262 hed axons expressed and selectively targeted proteolipid protein to compact myelin and did not degene
263 ere remarkably similar to that of the myelin proteolipid protein were previously isolated.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top